论文部分内容阅读
目的:探讨小儿肺炎支原体肺炎的临床诊断和治疗方法,分析其临床治疗效果。方法:选取2013年11月至2015年11月间该院收治的92例小儿肺炎支原体肺炎患者的资料进行分析,将患者平均分成观察组和对照组,对照组给予药物红霉素进行治疗,观察组采用药物阿奇霉素进行治疗,密切观察病情变化,并对临床疗效进行评价和对比。结果:观察组治愈31例,有效13例,无效2例,总有效率95.65%;对照组治愈12例,有效28例,无效6例,总有效率86.96%,观察组总有效率明显高与对照组,应用阿奇霉素治疗小儿肺炎支原体肺炎临床效果显著。结论:阿奇霉素和红霉素比较,一方面可明显的改善临床症状,有效消除肺炎支原体,另一方面减轻了药物的不良反应,提高了患儿耐受性,治疗效果显著,值得临床医生借鉴和推广使用。
Objective: To investigate the clinical diagnosis and treatment of children with Mycoplasma pneumoniae pneumonia and analyze its clinical effect. Methods: The data of 92 cases of children with Mycoplasma pneumoniae pneumonia admitted in our hospital from November 2013 to November 2015 were analyzed. The patients were equally divided into the observation group and the control group. The control group was given the drug erythromycin for observation. Group treated with drugs azithromycin, close observation of changes in condition, and clinical evaluation and comparison. Results: In the observation group, 31 cases were cured, 13 cases were effective, 2 cases were ineffective and the total effective rate was 95.65%. In the control group, 12 cases were cured, 28 cases were effective and 6 cases were ineffective. The total effective rate was 86.96% The control group, the application of azithromycin in children with Mycoplasma pneumoniae pneumonia clinical effect is significant. Conclusion: Azithromycin and erythromycin, on the one hand, can significantly improve the clinical symptoms and effective elimination of Mycoplasma pneumoniae, on the other hand reduce the adverse drug reactions and improve children’s tolerance, the treatment effect is significant, it is worth learning from clinicians and Promote use.